Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,771 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The use of antiviral agents for the management of severe influenza.
Smith JR, Ariano RE, Toovey S. Smith JR, et al. Crit Care Med. 2010 Apr;38(4 Suppl):e43-51. doi: 10.1097/CCM.0b013e3181c85229. Crit Care Med. 2010. PMID: 19935416 Review.
Safety profile of oseltamivir during the 2009 influenza pandemic.
Donner B, Bader-Weder S, Schwarz R, Peng MM, Smith JR, Niranjan V. Donner B, et al. Among authors: smith jr. Pharmacoepidemiol Drug Saf. 2011 May;20(5):532-43. doi: 10.1002/pds.2136. Pharmacoepidemiol Drug Saf. 2011. PMID: 21448900
Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.
Smith JR, Rayner CR, Donner B, Wollenhaupt M, Klumpp K, Dutkowski R. Smith JR, et al. Adv Ther. 2011 Nov;28(11):927-59. doi: 10.1007/s12325-011-0072-7. Epub 2011 Nov 1. Adv Ther. 2011. PMID: 22057727 Free PMC article. Review.
Oseltamivir in human avian influenza infection.
Smith JR. Smith JR. J Antimicrob Chemother. 2010 Apr;65 Suppl 2(Suppl 2):ii25-ii33. doi: 10.1093/jac/dkq013. J Antimicrob Chemother. 2010. PMID: 20215132 Free PMC article. Review.
Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, Ellis J, Bermingham A, Nicholson K, Zambon M. Stephenson I, et al. Clin Infect Dis. 2009 Feb 15;48(4):389-96. doi: 10.1086/596311. Clin Infect Dis. 2009. PMID: 19133796
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
Ward P, Small I, Smith J, Suter P, Dutkowski R. Ward P, et al. J Antimicrob Chemother. 2005 Feb;55 Suppl 1:i5-i21. doi: 10.1093/jac/dki018. J Antimicrob Chemother. 2005. PMID: 15709056 Review.
Safety and pharmacokinetics of oseltamivir at standard and high dosages.
Dutkowski R, Smith JR, Davies BE. Dutkowski R, et al. Among authors: smith jr. Int J Antimicrob Agents. 2010 May;35(5):461-7. doi: 10.1016/j.ijantimicag.2009.12.023. Epub 2010 Mar 1. Int J Antimicrob Agents. 2010. PMID: 20189775 Clinical Trial.
Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
Smith JR, Sacks S. Smith JR, et al. Int J Clin Pract. 2009 Apr;63(4):596-605. doi: 10.1111/j.1742-1241.2009.02010.x. Int J Clin Pract. 2009. PMID: 19335705
Active metabolite from Tamiflu solution is bioequivalent to that from capsule delivery in healthy volunteers: a cross-over, randomised, open-label study.
Brewster M, Smith JR, Dutkowski R, Robson R. Brewster M, et al. Among authors: smith jr. Vaccine. 2006 Nov 10;24(44-46):6660-3. doi: 10.1016/j.vaccine.2006.05.080. Epub 2006 Jun 9. Vaccine. 2006. PMID: 16797800 Clinical Trial.
A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination.
Morrison D, Roy S, Rayner C, Amer A, Howard D, Smith JR, Evans TG. Morrison D, et al. Among authors: smith jr. PLoS One. 2007 Dec 12;2(12):e1305. doi: 10.1371/journal.pone.0001305. PLoS One. 2007. PMID: 18074029 Free PMC article. Clinical Trial.
4,771 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback